Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis
J. Clin. Invest. Laurence M. Howard, et al. 109:233 doi:10.1172/JCI14374 [Go to this article.]

Table 1
Summary of histology of spinal cord sections from control- and anti-CD154–treated mice, 100 days after treatment and immunization